5. Conclusion
AS is a highly prevalent disease and its incidence is expected to increase further, due to ageing population in India. The development of MI approach has allowed surgeons to treat patients with multiple co-morbidities. Perceval sutureless valve also enhances the feasibility of MIAVR by quick and reproducible valve implantation along with decalcification of the aortic annulus. In our limited experience, the Perceval sutureless valve is most useful in MIAVR, combined procedure and in high risk patient’s sensitive to x-clamp and CPB time. Rate of Permanent Pacemaker implantation has been reduced significantly by technical changes and it will further reduces with introduction of new design Perceval sutureless valve. This valve also proves to be good alternate to TAVI in cost reduction. Satisfactory mid-term and long-term durability has been shown in various studies (18).
With increase in the number of Perceval sutureless valve implantation in India, the experience of other surgeons and center will also contribute to our findings and feasibility of its wide use.